STAT10h
How to protect HHS, FDA, NIH, and other health agencies from political interference
When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...
FDA approves new pain medication as an alternative to opioids: What to know about Journavx
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
STAT10h
With little fanfare, Biden administration stacked vaccine advisory committee with new members
With little fanfare, the Biden administration stacked a critical committee that helps set U.S. vaccination policy with new ...
FDA approves new type of nonopioid painkiller for acute pain
The Food and Drug Administration approved a new type of nonopioid painkiller, Journaxv, or suzetrigine, drugmaker Vertex ...
NewsX9h
How Much Will Newly Non-Opioid Painkiller Approved By FDA Cost You?
The FDA granted approval for Journavx after clinical trials demonstrated its effectiveness in post-surgical pain relief ...
pharmaphorum8h
Vertex bags first FDA okay for a non-opioid pain drug
Vertex Pharma has secured FDA approval for its non-opioid pain drug suzetrigine, becoming the first new class of pain medicine in the US in more than 20 years.
The FDA Issued a Class I Recall on Ready-to-Eat Broccoli Across 20 States
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
New type of non-opioid pain medication approved by FDA
( The Hill) – The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first ...
Vertex Pharmaceuticals Stock Jumps After FDA Approval for New Non-Opioid Painkiller
Journavx is the first and only approved non-opioid oral painkiller and the first new class of pain medicine approved in more ...
FDA approves Vertex’s non-opioid painkiller, first new kind of pain medicine in decades
The Vertex drug is a milestone after a long history of unsuccessful efforts to develop painkillers without the addictive potential of opioids.